TNF-α -863 polymorphisms and the risk of hepatocellular carcinoma

Experimental and Therapeutic Medicine

Volumn 3, Issue 3, 2012, Pages 513-518

  Yang, Yan ^a   Qiu, Xiao Qiang ^a,b   Yu, Hong Ping ^a   Zeng, Xiao Yun ^a   Bei, Chun Hua ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Polymorphisms; Single nucleotide polymorphism; TNF

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 84862925821     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.418     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Thun MJ, De Lancey JO, Center MMx, /xet al: The global burden of cancer: priorities for prevention. Carcinogenesis 31: 100-110, 2010.
3. Zhang C, Huang T and Yu J: Epidemiological analysis of primary liver cancer in the early 21st century in Guangxi province of China. Chin J Cancer 29: 545-550, 2010.
4. Yeh FS and Shen KN: Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res 47: 297-329, 1986.
5. Groopman JD, Wang JS, Scholl P, et al: Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can J Physiol Pharmacol 74: 203-209, 1996.
6. Thakur V, Guptan RC, Kazim SN, et al: Profile, sepectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 17: 165-170, 2002.
7. Lok AS, Heathcote EJ and Hoofnaque JH: Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120: 1828-1853, 2001.
8. Ino S: Natural history of hepatitis B and C virus infection. Oncology 62: 18-23, 2002.
9. Budhu A and Wang XW: The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 80: 1197-1213, 2006.
10. Ferrari C, Penna A, Bertoletti A, et al: Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infetions. Recent Results Cancer Res 154: 330-336, 1998.
11. Vgas GN: Immunobiology of persistent blood-borne viral infections. Dev Biol 102: 9-17, 2000.
12. Ho SY, Wang YJ, Chen HL, et al: Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-α promoter gene. Cancer Causes Control 15: 657-663, 2004.
13. Wang Y, Kato N, Hoshida Y, et al: Interleukin-1B gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37: 65-71, 2003.
14. Kim YJ, Lee HS, Im JP, et al: Association of transforming growth factor-beta1 gene polymorphisms with a hepatocel- lular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 35: 196-202, 2003.
15. Qi P, Chen YM, Wang H, et al: -509C>T polymorphism in the TGF-β1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection. Cancer Immunol Immunother 58: 1433-1440, 2009.
16. Skoog T, Hooft FM, Kallin B, et al: A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8: 1443-1449, 1999.
17. Kao PC, Wu JF, Ni YH, et al: Tumour necrosis factor-alpha promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver Int 30: 1448-1453, 2010.
18. *13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 14: 841-848, 2007.
19. Xia Q, Zhou L, Liu D, et al: Relationship between TNF- gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS One 6: e19606, 2011.